AveXis, Inc. | Booth # 23
AveXis is a gene therapy company focused on developing novel treatments and ensuring access for patients and families affected by rare and life-threatening neurological genetic diseases. Our goal is to utilise cutting-edge science to deliver a functional copy of a lost or defective gene, using a single-dose delivery method. (avexis.com)
Sanofi Genzyme | Booth # 20-22
Sanofi Genzyme focuses on developing specialty treatments for debilitating diseases that are often difficult to diagnose and treat, providing hope to patients and their families. (sanofigenzyme.com)
WARNING: We are aware that illegitimate companies are targeting our sponsors and exhibitors, calling to ‘offer’ to set you up with accommodation. These companies are often fraudulent. Please note that they are not affiliated with us and that the only way to register & book accommodation will be only through the Congress website (coming soon).
The ICNMD is organized on behalf of the Applied Research Group on Neuromuscular Diseases of the World Federation of Neurology.
Keep up to date with Conference News & Alerts. Sign Up
ICS International Conference Services
Alexandra Seppi, Conference Manager
Nussdorferstrasse 20/24, 1090 Vienna, Austria
P +43 1 3532024 ICNMD2020@icsevents.com